Bassel-Duby R, Jiang N Y, Bittick T, Madison E, McGookey D, Orth K, Shohet R, Sambrook J, Gething M J
Howard Hughes Medical Institute, Dallas, Texas.
J Biol Chem. 1992 May 15;267(14):9668-77.
Human tissue-type plasminogen activator (t-PA) is cleared rapidly from the circulation by hepatic receptors, one of which recognizes a site in the epidermal growth factor-like domain of the molecule. To define this site more precisely, we have used oligonucleotide-mediated mutagenesis to introduce amino acid substitutions at specific positions located in turns that connect antiparallel beta-sheets in the epidermal growth factor-like domain. Mutated t-PA proteins with amino acid substitutions of the tyrosine residue at position 67 showed markedly lower rates of endocytosis and degradation by cultured cells of the rat hepatoma (H4) line that express a specific receptor for t-PA, and their half-life in the circulation of rats was extended significantly because of a reduction in the rate of the rapid alpha-phase of clearance. The enzymatic properties and fibrinolytic activity of these mutants in vitro were not significantly different from those of wild-type t-PA. We conclude that tyrosine 67 comprises a key determinant in the clearance of t-PA by a specific hepatic receptor.
人组织型纤溶酶原激活剂(t-PA)通过肝脏受体从循环中迅速清除,其中一种受体识别该分子表皮生长因子样结构域中的一个位点。为了更精确地确定这个位点,我们使用寡核苷酸介导的诱变在表皮生长因子样结构域中连接反平行β折叠的转角处的特定位置引入氨基酸替换。在第67位酪氨酸残基发生氨基酸替换的突变型t-PA蛋白,被表达t-PA特异性受体的大鼠肝癌(H4)细胞系培养细胞内吞和降解的速率明显降低,并且由于清除快速α期速率的降低,它们在大鼠循环中的半衰期显著延长。这些突变体在体外的酶学性质和纤溶活性与野生型t-PA没有显著差异。我们得出结论,酪氨酸67是特定肝脏受体清除t-PA的关键决定因素。